Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea.

Cannabis is one of the oldest known medicinal plants, and a large variety of biological activities have been described. The main constituents, the cannabinoids, are thought to be most important for these activities. Although smoking of cannabis is by far the most common way of consumption, a significant part of medicinal users consume it in the form of a tea. However, not much is known about the composition of cannabis tea, or the effect of different parameters during preparation, handling or storage. In this study we used the high-grade cannabis available in Dutch pharmacies to study the cannabinoid composition of tea under standardized and quantitative conditions. Experimental conditions were systematically varied in order to mimic the possible variations made by medicinal users. During analysis there was a specific focus on the cannabinoid tetrahydrocannabinol and its acidic precursor, tetrahydrocannabinolic acid. Also the role of non-psychoactive cannabinoids as components of cannabis tea are discussed. The results obtained in this study provide a clear quantitative insight in the phytochemistry of cannabis tea preparation and can contribute to a better appreciation of this mode of cannabis administration.

[1]  E. R. Garrett,et al.  Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol. , 1974, Journal of Pharmacy and Science.

[2]  N. Doorenbos,et al.  Mississippi-grown Cannabis sativa L: preliminary observation on chemical definition of phenotype and variations in tetrahydrocannabinol content versus age, sex, and plant part. , 1971, Journal of pharmaceutical sciences.

[3]  F. Musshoff,et al.  Determination of cannabinoids in hemp food products by use of headspace solid-phase microextraction and gas chromatography–mass spectrometry , 2004, Analytical and bioanalytical chemistry.

[4]  R. Verpoorte,et al.  Structure elucidation of the tetrahydrocannabinol complex with randomly methylated beta-cyclodextrin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  T. Veress,et al.  Determination of cannabinoid acids by high-performance liquid chromatography of their neutral derivatives formed by thermal decarboxylation. I. Study of the decarboxylation process in open reactors , 1990 .

[6]  O. Zoller,et al.  High-performance liquid chromatographic determination of Δ9-tetrahydrocannabinol and the corresponding acid in hemp containing foods with special regard to the fluorescence properties of Δ9-tetrahydrocannabinol. , 2000 .

[7]  Robert Verpoorte,et al.  Preparative Isolation of Cannabinoids from Cannabis sativa by Centrifugal Partition Chromatography , 2004 .

[8]  Vera D. Rubin,et al.  Effects of Cannabis in Another Culture. (Book Reviews: Ganja in Jamaica. A Medical Anthropological Study of Chronic Marihuana Use) , 1975 .

[9]  J. Verweij,et al.  Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11) , 2005 .

[10]  M. Elsohly,et al.  Constituents of Cannabis sativa L. XVII. A review of the natural constituents. , 1980, Journal of natural products.

[11]  M. Upfal,et al.  Concentration of marijuana metabolites in the urine after ingestion of hemp seed tea. , 1998, Journal of occupational and environmental medicine.

[12]  K. Verhoeckx,et al.  Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways. , 2006, International immunopharmacology.

[13]  Y. Shoyama,et al.  Biosynthesis of cannabinoid acids , 1975 .

[14]  E. R. Garrett,et al.  Physicochemical Properties, Solubility, and Protein Binding of Δ9 -Tetrahydrocannabinol , 1974 .

[15]  Y. Choi,et al.  Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR. , 2004, Chemical & pharmaceutical bulletin.

[16]  Ich Harmonised,et al.  INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .

[17]  K. Järvinen,et al.  Effects of RM-β-CD on sublingual bioavailability of Δ9-tetrahydrocannabinol in rabbits , 2005 .

[18]  G. Nelson,et al.  A positive cannabinoids workplace drug test following the ingestion of commercially available hemp seed oil. , 1997, Journal of analytical toxicology.